Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1981-05-27
1982-10-26
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
260112R, 260121, 424 85, 424 87, 424 88, 424 89, 424 90, 424 91, A61K 39385
Patent
active
043561705
ABSTRACT:
Antigenic polysaccharides are modified to generate a terminally-located aldehyde group by controlled oxidation of vicinal hydroxyl groups, e.g. of unlinked terminal non-reducing sialic acid residues. In some cases where there is a reducing end group, e.g. of the type N-acetylmannosamine residue, it can be made into the most susceptible site for oxidation by initially reducing it to its open chain hydroxyl form, e.g. N-acetylmannosaminitol. The vicinal hydroxyl oxidation is controlled to yield a reactive aldehyde group which is then covalently linked to a free amino group of a selected protein by reductive amination. The resulting polysaccharide-protein conjugates are soluble and have been found to have enhanced antigenicity compared to the polysaccharide alone. This terminal aldehyde:free amine group reductive amination can be applied to various polysaccharide antigens and various well-tolerated proteins, preferably protein immunogens. For example, meningococcal group A, B and C polysaccharides have been linked to tetanus toxoid to give soluble conjugates which have been found to have advantageous immunogenic properties.
REFERENCES:
patent: 3847890 (1974-11-01), Green et al.
patent: 3947352 (1976-03-01), Cuatrecasas et al.
patent: 4003792 (1977-01-01), Mill et al.
patent: 4093607 (1978-06-01), Sela et al.
patent: 4125492 (1978-11-01), Cuatrecasas et al.
patent: 4185090 (1980-01-01), McIntire
patent: 4203893 (1980-05-01), Pery et al.
patent: 4259232 (1981-03-01), Carrico et al.
patent: 4303638 (1981-12-01), Tayot et al.
patent: 4308254 (1981-12-01), Tayot et al.
patent: 4310514 (1982-01-01), Durette
patent: 4315913 (1982-02-01), Durette
Archives of Biochemistry & Biophysics, vol. 181, 1977, Schwartz et al., pp. 542-549.
Jennings Harold J.
Lugowski Czeslaw
Canadian Patents & Development Ltd.
Schain Howard E.
Thomson Alan A.
LandOfFree
Immunogenic polysaccharide-protein conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic polysaccharide-protein conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic polysaccharide-protein conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-947787